Who is the lecturer for the JPI seminar scheduled on April 9th, 2026?

The lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare.

What is the date and time of the JPI seminar on building a drug discovery ecosystem?

The seminar will be held on Thursday, April 09, 2026, from 09:30 to 11:30, and archive streaming applications will be accepted after it ends.

How is the problem of 'drug loss' defined in the lecture overview?

It is defined as a problem where medicines approved in Europe and the United States are not developed in Japan, risking that innovative medicines may not be provided in Japan.

What are the three main aims of the discussions between the public and private sectors in Japan?

The discussions aim to strengthen Japan's drug discovery capabilities, rapidly deliver the latest medicines to the public, and build a social system where the cycle of investment and innovation is sustained.

AI News NQ Analysis

[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th

NQ Score 50/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: Who is the lecturer for the JPI seminar scheduled on April 9th, 2026?: A: The lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare.
Q: What is the main topic or title of the lecture to be held by Mr. Yasuhiro Araki?: A: The title is 'The Deepening "Drug Loss" Problem and Strengthening Japan's Drug Discovery Capabilities Ministry of Health, Labour and Welfare: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials ~ Regulatory Harmonization and Concrete Measures for the Rapid Delivery of the Latest Medicines ~'.
Q: What is the date and time of the JPI seminar on building a drug discovery ecosystem?: A: The seminar will be held on Thursday, April 09, 2026, from 09:30 to 11:30, and archive streaming applications will be accepted after it ends.
Q: How is the problem of 'drug loss' defined in the lecture overview?: A: It is defined as a problem where medicines approved in Europe and the United States are not developed in Japan, risking that innovative medicines may not be provided in Japan.
Q: What are the three main aims of the discussions between the public and private sectors in Japan?: A: The discussions aim to strengthen Japan's drug discovery capabilities, rapidly deliver the latest medicines to the public, and build a social system where the cycle of investment and innovation is sustained.